Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy. - Université de Lille
Article Dans Une Revue Intensive Care Medicine Année : 2018

Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy.

Fichier non déposé

Dates et versions

hal-04314015 , version 1 (29-11-2023)

Identifiants

Citer

Satoshi Yamaga, Shinichiro Ohshimo, Nobuaki Shime, Saad Nseir, Boualem Sendid, et al.. Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy.. Intensive Care Medicine, 2018, Intensive Care Medicine, 44, pp.399-400. ⟨10.1007/s00134-018-5068-1⟩. ⟨hal-04314015⟩

Collections

RIIP UNIV-LILLE
11 Consultations
0 Téléchargements

Altmetric

Partager

More